NEO - ネオス・ファ―マシュ―ティカルズ (NeoGenomics Inc.) ネオス・ファ―マシュ―ティカルズ

 NEOのチャート


 NEOの企業情報

symbol NEO
会社名 Neos Therapeutics Inc (ネオス・ファ―マシュ―ティカルズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Precision Instruments  
業種 ヘルスケア施設_サ―ビス   医療関連(Health Care)
概要 事業概要 ネオゲノミクス(NeoGenomics Inc.)はがんに焦点を当てた遺伝子検査ラボのネットワークのオペレーターである。同社は実験室試験事業を運営する。実験室試験事業は病院、病理学者、腫瘍専門医、他の臨床医及び研究者に検査サービスを提供する。同社はフロリダ州マイアーズとタンパ、カリフォルニア州のアリソビエホ、フレズノ、アーバイン、ウエストサクラメント、並びにテキサス州のヒューストンとテネシー州のナッシュビルで実験室を有する。その実験室は細胞遺伝学、蛍光in-situハイブリダイゼーション(FISH)、フローサイトメトリー、免疫組織化学(IHC)、分子検査および病理学相談を含む検査サービスを提供する。製薬サービスと臨床試験グループは、製薬顧客の腫瘍学プログラムを、発見から商品化までサポートするために、テストサービスを提供する。同社は分子スクリーニングのための最適なプラットフォームを推薦し、意味のあるデータを収集するために情報科学を用いてその発見ツールを支援することによって、顧客がバイオマーカー仮説を立てるのに役立つ。   ネオス・ファ―マシュ―ティカルズは米国の医薬品会社。主に薬剤送達技術を利用し、既に商品化されている製薬の改良、開発に従事する。薬剤候補に、注意欠陥多動障害(ADHD)治療薬で、患者の負担が軽い徐放性タイプの経口薬を開発する。また、ADHD治療薬のメチルフェニデ―トとアンフェタミンの両方を取り入れた製薬も開発する。本社はキサス州。   NeoGenomics, Inc. specializes in cancer genetics testing and information services. The Company provides one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. The Company's Pharma Services division serves pharmaceutical clients in clinical trials and drug development. Headquartered in Fort Myers, FL, NeoGenomics operates CAP accredited and CLIA certified laboratories in Ft. Myers and Tampa, Florida; Aliso Viejo, Carlsbad and Fresno California; Houston, Texas; Atlanta, Georgia; Nashville, Tennessee; Rolle, Switzerland, and Singapore. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations throughout the United States, and pharmaceutical firms in Europe and Asia.
本社所在地 2940 N. Hwy. 360 Grand Prairie TX 75050 USA
代表者氏名 Douglas M. VanOort Douglas M. VanOort
代表者役職名 Chairman of the Board Chief Executive Officer 取締役会長兼最高経営責任者
電話番号 +1 941-923-1949
設立年月日 34639
市場名 NASDAQ National Market System
ipoyear ―年
従業員数 138人
url www.neostx.com
nasdaq_url https://www.nasdaq.com/symbol/neo
adr_tso
EBITDA EBITDA(百万ドル) 26.99500
終値(lastsale) 14.34
時価総額(marketcap) 1170709082.04
時価総額 時価総額(百万ドル) 1268.162
売上高 売上高(百万ドル) 262.01400
企業価値(EV) 企業価値(EV)(百万ドル) 1397.261
当期純利益 当期純利益(百万ドル) -4.77900
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 NeoGenomics Inc. revenues increased 10% to $131.2M. Net income applicable to common stockholders totaled $3.7M vs. loss of $5.9M. Revenues reflect Clinical testing segment increase of 7% to $116.5M Pharma Services segment increase of 30% to $14.7M. Net Income reflects Stock-based Compensation in R&D decrease of 18% to $269K (expense).

 NEOのテクニカル分析


 NEOのニュース

   Samsung nâng cp TV nhm n game th  2021/06/30 12:00:00 VnExpress
Dòng TV Neo QLED c thit k phù hp cho vic chi game 4K vi tc khung hình 120 Hz, tr u vào 5 ms, hn ch git khung hình, âm thanh kch tính
   TP Finance (TP Fico): ng dng dch v tài chính tiêu dùng t TPBank  2021/06/30 07:18:03 Sài Gòn Gii Phóng
Nn tng k thut s TP Finance (TP Fico) da trên gii pháp FinnOne Neo t Nucleus Software. ây là công ty phn mm hàng u chuyên cung cp các gii pháp cho vay và giao dch ngân hàng cho các công ty tài chính hàng u trên toàn cu.
   Realme Buds 2 Neo   2021/06/29 12:17:43 Maharashtra Times
. . . .
   Neo Plaza  2021/06/29 12:14:00 Sigmalive Cyprus
Neo Plaza, , , , . , Neo Plaza , . , , . , Neo Plaza . Neo Plaza, , , .
   Neo Plaza  2021/06/29 11:37:44 Politis Cyprus
Neo Plaza .
   Realme Buds 2 Neo   2021/06/29 12:17:43 Maharashtra Times
. . . .
   Neo Plaza  2021/06/29 12:14:00 Sigmalive Cyprus
Neo Plaza, , , , . , Neo Plaza , . , , . , Neo Plaza . Neo Plaza, , , .
   Neo Plaza  2021/06/29 11:37:44 Politis Cyprus
Neo Plaza .
   Neo Plaza ()  2021/06/29 10:58:22 Philenews Cyprus
Neo Plaza, , , , . , Neo Plaza , . , , . , Neo Plaza . Neo Plaza , .
   21   2021/06/29 10:58:11 Watani
3 ( 21 ) 2 2021. A320 Neo []
   Earnings Scheduled For May 13, 2021  2021/05/13 08:15:48 Benzinga
Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ: CASI ) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million. • Liquidia (NASDAQ: LQDA ) is projected to report quarterly loss at $0.21 per share on revenue of $870.00 thousand. • ARKO (NASDAQ: ARKO ) is expected to report quarterly loss at $0.11 per share on revenue of $1.39 billion. • Evaxion Biotech (NASDAQ: EVAX ) is expected to report earnings for its first quarter. • OneSmart Intl Edu Group (NYSE: ONE ) is likely to report quarterly loss at $0.10 per share on revenue of $151.43 million. • Alleghany (NYSE: Y ) is estimated to report quarterly earnings at $0.41 per share on revenue of $74.00 million. • NICE (NASDAQ: NICE ) is expected to report quarterly earnings at $1.49 per share on revenue of $450.84 million. • YETI Holdings (NYSE: YETI ) is projected to report quarterly earnings at $0.21 per share on revenue of $220.37 million. • Bilibili (NASDAQ: BILI ) is estimated to report quarterly loss at $0.
   eToro review: Cryptocurrency trading with a community of experienced investors  2021/05/12 21:03:23 Business Insider
Summary List Placement Table of Contents: Masthead Sticky Is eToro right for you? You may like eToro if you… You may not like eToro if you... Want to trade Bitcoin, Dogecoin, Ethereum, Litecoin, and other popular virtual assets Are interested in following experienced traders to improve your investment strategies Value educational resources and support when using investment platforms Want mobile app access Are a resident of New York, Delaware, Minnesota, New Hampshire, Nevada, Puerto Rico, Tennessee, Hawaii, Guam, American Samoa, and the US Virgin Islands Want to access to a larger selection of cryptocurrencies (eToro USA currently offers 17) Like to use margin accounts for additional buying power eToro is an online cryptocurrency exchange offering Bitcoin and more than 15 other cryptocurrencies. While the company has global reach, it has separate offerings for US traders. US investors have three options: trade on their own, use eToro's CopyTrader ™ system to mimic the portfolios of successful investors, or invest in one of its Copy Portfolios, which are portfolios of digital currencies overseen by eToro.
   NeoGenomics Exercises Option To Acquire Remaining Stake In Inivata For $390M  2021/05/05 12:38:39 Benzinga
NeoGenomics Inc (NASDAQ: NEO ) has agreed to acquire the remaining stake in Inivata Ltd, a commercial-stage liquid biopsy platform company headquartered in England. The acquisition follows a $25 million minority equity investment by NeoGenomics in Inivata in May last year, at which time NeoGenomics was granted a fixed price option … Full story available on Benzinga.com
   Oppenheimer shares 12 small-company stocks to buy while this unloved part of the market is beaten down and before it makes a comeback  2021/04/20 15:48:05 Business Insider
Summary List Placement Up until this week, it seemed like the stock market would continue enjoying a strong run this year with the S&P 500 having hit all-time highs four times since the beginning of 2021. Most recently, the S&P 500 closed above 4,185 for the first time on April 16. April 1 also marked a closing milestone for the index as it surpassed 4,000 points . The same can't be said of the Russell 2000. Even though small-caps are outperforming their larger counterparts on a year-to-date basis, they've failed to continue generating lofty gains these past couple of months as the Russell 2000's three-month return of 5.2% now lag the S&P 500's performance of nearly 11% . However, the small-cap index still houses some appealing opportunities for investors given that the Russell 2000 is just taking a breather and can resume its powerful run, according to Ari Wald, the head of technical analysis at Oppenheimer & Co. That's because technical analysis shows small caps failed to reach fresh highs in April as a result of a bull-market rotation rather than money becoming less concentrated at a major peak.
   If You Invested $1,000 In Neo Crypto On Jan. 1, Here's How Much You Would Have Now  2021/04/19 05:36:25 Benzinga
Neo (NEO) emerged as China’s first public blockchain … Full story available on Benzinga.com

 関連キーワード  (ヘルスケア施設_サ―ビス 米国株 ネオス・ファ―マシュ―ティカルズ NEO NeoGenomics Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)